Showing results (921-930 of 4,873) with videos related to
Sort By:
Pageof 488
Urologic Oncology|January 24, 2017
Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladderTohru Nakagawa, Satoru Taguchi, Yukari Uemura, et al.Urologic Oncology|October 26, 2016
Emerging role of checkpoint inhibition in localized bladder cancerParminder Singh, Peter BlackUrologic Oncology|October 26, 2016
Partial nephrectomy vs. radical nephrectomy for renal tumors: A meta-analysis of renal function and cardiovascular outcomesZheng Wang, Ganggang Wang, Qinghua Xia, et al.Urologic Oncology|November 16, 2016
Association of a TFAM haplotype with aggressive prostate cancer in overweight or obese Mexican Mestizo menJesús Benítez Granados, Juan Pablo Méndez, Guillermo Feria-Bernal, et al.Urologic Oncology|January 17, 2017
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technologyRobert Steven Gerhard, Dattatraya Patil, Yuan Liu, et al.Urologic Oncology|April 15, 2017
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomyDaniel M Tennenbaum, Brandon J Manley, Emily Zabor, et al.Urologic Oncology|April 17, 2017
Regionalization of radical cystectomy in the United StatesChristopher B Anderson, Renee Gennarelli, Harry W Herr, et al.Urologic Oncology|September 16, 2019
Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancerJenny Roggisch, Thorsten Ecke, Stefan KochUrologic Oncology|September 21, 2019
Optical biopsy of penile cancer with in vivo confocal laser endomicroscopyEugene Shkolyar, Mark A Laurie, Kathleen E Mach, et al.Urologic Oncology|April 30, 2015
The role of microRNAs 371 and 34a in androgen receptor control influencing prostate cancer behaviorKatia R M Leite, Denis Reis Morais, Manuel Garcia Florez, et al.Pageof 488